Log in
Enquire now
‌

US Patent 10889610 Alpha-D-galactoside inhibitors of galectins

Patent 10889610 was granted and assigned to Galecto Biotech on January, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Galecto Biotech
Galecto Biotech
Current Assignee
Galecto Biotech
Galecto Biotech
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10889610
Patent Inventor Names
Fredrik Zetterberg0
Hakon Leffler0
Ulf Nilsson0
Date of Patent
January 12, 2021
Patent Application Number
16313628
Date Filed
July 9, 2017
Patent Citations
‌
US Patent 10253059 Hybrid galactoside inhibitor of galectins
‌
US Patent 10464964 Galactoside inhibitor of galectins
0
Patent Citations Received
‌
US Patent 11919921 Galactoside inhibitor of galectins
0
‌
US Patent 11377464 Galactoside inhibitor of galectins
0
Patent Primary Examiner
‌
Eric Olson
Patent abstract

The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10889610 Alpha-D-galactoside inhibitors of galectins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.